Fresenius | FRE - Assets

Stock Price
40.01
Daily Change
-0.24 -0.60%
Monthly
-10.27%
Yearly
-1.55%
Q2 Forecast
39.19

Fresenius reported EUR42.46B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Alcon AG USD 31.56B 31M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Beiersdorf EUR 12.76B 166M Dec/2025
DaVita Healthcare Partners USD 17.48B 75.79M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
E.ON EUR 110.68B 3.65B Dec/2025
Essilor EUR 63.9B 1.97B Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 31B 115.33M Dec/2025
Getinge SEK 63.92B 4.3B Dec/2024
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GN Store Nord DKK 29.23B 170M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Philips EUR 26.94B 605M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
RWE EUR 101.72B 5.51B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025